The global anti-rheumatics market is projected to grow at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global anti-rheumatics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The anti-rheumatics market is segmented on the basis of drug class, type, and region. The anti-rheumatics market is segmented as below:

By Drug Class:

  • corticosteroids
  • disease modifying anti-rheumatic drugs
  • nonsteroidal anti-inflammatory drugs
  • uric acid drugs
  • others



By Type:

  • over-the-counter drugs
  • prescription-based drugs



By Region:

  • Asia-Pacific
  • Europe
  • North America
  • Middle East and Africa (MEA)
  • South America



The anti-rheumatics industry is characterized by a high level of market share concentration. The market research report covers the analysis of key stake holders of the anti-rheumatics market. Some of the leading players profiled in the report include AbbVie Inc., Amgen Inc., Bristol Myers Squibb (BMS), Eli Lilly And Company, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Roche Holding AG, UCB SA, among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

  • To analyze and forecast the market size of the global anti-rheumatics market.
  • To classify and forecast the global anti-rheumatics market based on drug class, type, and region.
  • To identify drivers and challenges for the global anti-rheumatics market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global anti-rheumatics market.
  • To conduct pricing analysis for the global anti-rheumatics market.
  • To identify and analyze the profile of leading players operating in the global anti-rheumatics market.



Why Choose This Report

  • Gain a reliable outlook of the global anti-rheumatics market forecasts from 2021 to 2027 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.